Searchable abstracts of presentations at key conferences in endocrinology

ea0073ep70 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Hospital admission, a good time to optimize treatment and rethink the diagnosis

Elizabeth Lorenzo Hernández , Cobos Palacios Lidia , Viyey Kishore Doulatram Gamgaram , Ricardo Gómez Huelgas

IntroductionPrediabetes and type 2 diabetes prevalence in children and teenagers has been rising lately, according to obesity increase in this population. Diabetes is the first cause of kidney failure in this individuals. These clinical entities are associated with hypertension and dyslipidemia, leading to an increased risk for cardiovascular disease. In this case, as a result of the presence of a diabetic complication, the differential diagnosis of the ...

ea0073aep250 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Evaluation of the results of weight loss at 1 year after bariatric surgery at the regional university hospital of malaga

Silvia Patricia Alonso Gallardo , Viyey Kishore Doulatram Gamgaram , José Abuín Fernández , Marin Montserrat Gonzalo , Sergio Valdés Hernández

IntroductionMorbid obesity is a very prevalent disease, bariatric surgery being a fundamental pillar in its treatment.ObjectiveTo analyze the results of weight loss at 1 year in patients operated on gastric bypass and sleeve at the Regional University Hospital (HRU) of Malaga.MethodsRetrospective observational study, with a follow-up period of 1 year, of 215 patie...

ea0073aep700 | Thyroid | ECE2021

Factitious thyrotoxicosis, a diagnostic challenge

José Abuín Fernández , Viyey Kishore Doulatram Gamgaram , Pineda Cantero Araceli , Ignacio Ruíz García , Olveira Fuster Gabriel

IntroductionThe term factitious thyrotoxicosis is defined as an excess of thyroid hormone in the body caused by the ingestion of exogenous thyroid hormone. It can be intentional, usually in patients with psychiatric disorders, or accidentally. Another possible cause is the inappropriate use of thyroid hormone for the treatment of obesity, depression or infertility.Case reportWe present the case of a 32-year-o...

ea0073ep103 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

From type 2 diabetes to cardiac arrest

Viyey Kishore Doulatram Gamgaram , Pineda Cantero Araceli , José Abuín Fernández , Cobos Palacios Lidia , Olveira Fuster Gabriel

IntroductionGastrointestinal adverse effects such as nausea and vomiting are widely described for GLP-1 receptor agonists (arGLP-1). We highlight Semaglutide, a drug that needs to start its administration at a reduced dose, to be able to increase the dose later with better tolerance and adherence of the patient. Not doing it this way can lead the patient to have serious adverse effects such as incoercible vomiting or profuse diarrhea that entails serious...